🔗 Share this article

Chancellor Reeves has stated she is planning "targeted action to tackle cost of living issues" in next month's Budget.

Speaking to the BBC, she stated that reducing price rises is a collective responsibility of both the administration and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Possible Energy Cost Measures

Sources suggest the administration could intervene to bring down energy bills, for example by reducing the current 5% level of value-added tax charged on energy.

Another approach is to reduce some of the policy costs currently added to bills.

Budgetary Limitations and Analyst Expectations

The government will obtain the latest assessment from the official forecaster, the Office for Budget Responsibility, on Monday, which will show how much space there is for these actions.

The consensus from the majority of economists is that the Chancellor will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on the same day, analysis indicated there was a £22bn deficit for the chancellor to address, which is at the lower end of forecasts.

"There's a shared job between the central bank and the administration to bear down further on some of the causes of inflation," the Chancellor informed the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on likely tax rises, the chancellor said the latest data from the OBR had not altered her commitment to manifesto promises not to increase tax levels on earnings tax, VAT or National Insurance.

She attributed an "unpredictable world" with increasing geopolitical and commercial tensions for the Budget revenue measures, likely to be directed on those "most able to pay."

International Trade Tensions

Addressing concerns about the UK's trade ties with China she said: "Our security interests invariably take priority."

Last week's announcement by Chinese authorities to increase export controls on rare earths and other materials that are essential for high-technology production led US President Donald Trump to propose an additional 100% tariff on imports from China, raising the prospect of an full-scale trade war between the two largest economies.

The American finance chief described China's action "economic coercion" and "a international production control attempt."

Questioned on considering the American proposal to join its dispute with the Asian nation, Reeves said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the world economy and causes further challenges."

"In my view there are areas where we must confront China, but there are also important chances to sell into China's economy, including banking sector and other areas of the economic system. We've got to achieve that equilibrium appropriate."

The Treasury chief also stated she was working with G7 counterparts "regarding our own essential resources strategy, so that we are less reliant."

Health Service Medicine Costs and Investment

The Chancellor also recognized that the price the National Health Service pays for pharmaceuticals could go up as a consequence of ongoing talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or scrapping investments in the United Kingdom, with several attributing the insufficient payments they are getting.

Last month, the government science advisor said the price the NHS pays for medicines would must go up to prevent firms and drug research funding leaving the UK.

The Chancellor informed media: "We have seen because of the cost structure, that drug testing, innovative medicines have not been provided in the UK in the way that they are in other EU nations."

"Our aim is to ensure that patients receiving treatment from the National Health Service are can obtain the best critical drugs in the world. And so we are reviewing these issues, and... aiming to obtain more capital into the UK."